Browse > Article

Hesperidin Ameliorates TNF-${\alpha}$-Mediated Insulin Resistance in Differentiated 3T3-L1 Cells  

Chae, Byeong Suk (College of Pharmacy, Woosuk University)
Shin, Tae Yong (College of Pharmacy, Woosuk University)
Publication Information
Natural Product Sciences / v.18, no.4, 2012 , pp. 254-260 More about this Journal
Abstract
Adipose inflammation is linked to the development of insulin resistance and type 2 diabetes. Hesperidin (HES) is a flavonoid with antioxidant, anti-inflammatory and anti-diabetic properties. However, whether HES improves inflammation-mediated insulin resistance in adipose tissues remains unclear. The purpose of this study was to investigate whether HES attenuates inflammation-mediated insulin resistance in adipose tissue. Herein, RAW 264.7 cells and differentiated 3T3-L1 adipocytes were pretreated with various concentrations of HES in complete media for 1 h and then cultured in the presence or absence of LPS or TNF-${\alpha}$. Our results demonstrated that HES remarkably inhibited LPS-induced production of IL-6, TNF-${\alpha}$, and NO by RAW 264.7 cells in a dose-dependent manner. Also, HES inhibited TNF-${\alpha}$-induced production of IL-6 and $PGE_2$ in differentiated 3T3-L1 cells, while upregulated TNF-${\alpha}$-suppressed expression of adiponectin and PPAR-${\gamma}$ mRNA. These findings suggest that HES may ameliorate inflammation-mediated insulin resistance in adipose tissue.
Keywords
Hesperidin; IL-6; $PGE_2$; Adiponectin; PPAR-${\gamma}$; Insulin resistance; Adipocyte;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Henkel, J., Neuschafer-Rube, F., Pathe-Neuschafer-Rube, A., and Püschel, G. P., Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology 50, 781-790 (2009).   DOI   ScienceOn
2 Hosch, S.E., Olefsky, J.M., and Kim, J.J., APPLied mechanics: uncovering how adiponectin modulates insulin action. Cell Metab. 4, 5-6 (2006).   DOI   ScienceOn
3 Hsieh, P.S., Jin, J.S., Chiang, C.F., Chan, P.C., Chen, C.H., and Shih, K.C., COX-2-mediated inflammation in fat is crucial for obesitylinked insulin resistance and fatty liver. Obesity (Silver Spring) 17, 1150-1157 (2009).
4 Jain, M. and Parmar, H.S., Evaluation of antioxidative and antiinflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm. Res. 60, 483-491 (2011).   DOI   ScienceOn
5 Jung, U.J., Lee, M.K., Park, Y.B., Kang, M.A., and Choi, M.S., Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell. Biol. 38, 1134-1145 (2006).   DOI   ScienceOn
6 Kim, H.J., Higashimori, T., Park, S.Y., Choi, H., Dong, J., Kim, Y.J., Noh, H.L., Cho, Y.R., Cline, G.., Kim, J.H., Bachmann, R.A., and Chen, J., Interleukin-6 and insulin resistance. Vitam. Horm. 80, 613-633 (2009).
7 Klover, P.J., Clementi, A.H., and Mooney, R.A., Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146, 3417-3427 (2005).   DOI   ScienceOn
8 Klover, P.J., Zimmers, T.A., Koniaris, L.G., and Mooney, R.A., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789 (2003).   DOI   ScienceOn
9 Liu, T.T., Shih, K.C., Kao, C.C., Cheng, W.T., and Hsieh, P.S., Importance of cyclooxygenase 2-mediated low-grade inflammation in the development of fructose-induced insulin resistance in rats. Chin. J. Physiol. 52, 65-71 (2009).
10 Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., and Matsuzawa, Y., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099 (2001).   DOI   ScienceOn
11 Matsunaga, T., Shoji, A., Gu, N., Joo, E., Li, S., Adachi, T., Yamazaki, H., Yasuda, K., Kondoh, T., and Tsuda, K., ${\gamma}$-Tocotrienol attenuates TNF-${\alpha}$-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol. Med. Report 5, 905-909 (2012).
12 Meshkani, R. and Adeli, K., Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 42, 1331-1346 (2009).   DOI   ScienceOn
13 Perreault, M. and Marette, A., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7, 1138-43 (2001).   DOI   ScienceOn
14 Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M., Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J. Am. Med. Assoc. 286, 327-334 (2001).   DOI   ScienceOn
15 Ricote, M., and Glass, C. K., PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta. 1771, 926-935 (2007).   DOI   ScienceOn
16 Ruan, H., and Lodish, H.F., Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 14, 447-455 (2003).   DOI   ScienceOn
17 Schultz, O., Oberhauser, F., Saech, J., Rubbert-Roth, A., Hahn, M., Krone, W., and Laudes, M., Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One 5, e14328-14334 (2010).   DOI   ScienceOn
18 Senn, J.J., Klover, P.J., Nowak, I.A., and Mooney, R.A., Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391-3399 (2002).   DOI   ScienceOn
19 Senn, J.J., Klover, P.J., Nowak, I.A., Zimmers, T.A., Koniaris, L.G., Furlanetto, R.W., and Mooney, R.A., Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746 (2003).   DOI   ScienceOn
20 Sharma, A.M. and Staels, B., Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92, 386-395 (2007).
21 Sun, H., Zhang, Y., Gao, P., Li, Q., Sun, Y., Zhang, J., and Xu, C., Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. Mol. Cell. Biochem. 347, 183-189 (2011).   DOI
22 Staels, B., PPAR agonists and the metabolic syndrome. Therapie. 62, 319-326 (2007).   DOI   ScienceOn
23 Vozarova, B., Weyer, C., Hanson, K., Tataranni, P.A., Bogardus, C., and Pratley, R.E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res. 9, 414-417 (2001).   DOI   ScienceOn
24 Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and Ferrante, Jr A.W., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
25 Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., and Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
26 Yeh, C.C., Kao, S.J., Lin, C.C., Wang, S.D., Liu, C.J., and Kao, S.T., The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80, 1821-1831 (2007).   DOI   ScienceOn
27 Zhang, D., Sun, M., Samols, D., and Kushner, I., STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271, 9503-9509 (1996).   DOI
28 Buechler, C., Wanninger, J., and Neumeier, M., Adiponectin, a key adipokine in obesity related liver diseases. World J. Gastroenterol. 17, 2801-2811 (2011).
29 Ajuwon, K.M. and Spurlock M.E., Adiponectin inhibits LPS-induced NFkappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-1225 (2005).   DOI   ScienceOn
30 Akiyama, S., Katsumata, S., Suzuki, K., Ishimi, Y., Wu, J., and Uehara, M., Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 46, 87-92 (2010).
31 Dallaire, P., Bellmann, K., Laplante, M., Gelinas, S., Centeno-Baez, C., Penfornis, P., Peyot, M.L., Latour, M.G., Lamontagne, J., Trujillo, M.E., Scherer, P.E., Prentki, M., Deshaies, Y., and Marette, A., Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptorgamma agonism. Diabetes 57, 1999-2011 (2008).   DOI   ScienceOn
32 Akiyama, S., Katsumata, S., Suzuki, K., Nakaya, Y., Ishimi, Y., and Uehara, M., Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci. Biotechnol. Biochem. 73, 2779-2782 (2009).   DOI   ScienceOn
33 Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., Capeau, J., and Feve, B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4-12 (2006).
34 Berg, A.H. and Scherer, P.E., Adipose Tissue, Inflammation, and Cardiovascular Disease. Circulation Research 96, 939-949 (2005).   DOI   ScienceOn
35 De Taeye, B.M., Novitskaya, T., McGuinness, O.P., Gleaves, L., Medda, M., Covington, J.W., and Vaughan, D.E., Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293, E713-725 (2007).   DOI   ScienceOn
36 Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P., and Bahouth, S.W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282 (2004).   DOI   ScienceOn
37 Fontana, L., Eagon, J.C., Trujillo, M.E., Scherer, P.E., and Klein, S., Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabete, 56, 1010-1013 (2007).   DOI   ScienceOn
38 Garg, A., Garg, S., Zaneveld, L.J., and Singla, A.K., Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother. Res. 15, 655-669 (2001).   DOI   ScienceOn
39 Han, D.I., Hwang, B.Y., Hwang, S.Y., Park, J.H., Son, K.H., Lee, S.H., Chang, S.Y., Kang, S.J., Ro, J.S., and Lee, K.S., Isolation and quantitative analysis of hesperidin from Aurantii Fructus. Kor. J. Pharmacogn. 32, 93-97 (2001).